Evidence map›Paper›PMID 27021328›Full record

ArticleAntimicrobial agents and chemotherapy2016

Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.

Anderson Ramos da Silva, João Batista de Andrade Neto, Cecília Rocha da Silva, Rosana de Sousa Campos, Rose Anny Costa Silva, Daniel Domingues Freitas, Francisca Bruna Stefany Aires do Nascimento, Larissa Nara Dantas de Andrade, Letícia Serpa Sampaio, Thalles Barbosa Grangeiro and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Effect of Mn(II) and Co(II) on Anti-Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Anderson Ramos da SilvaSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
João Batista de Andrade NetoSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Cecília Rocha da SilvaSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Rosana de Sousa CamposSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Rose Anny Costa SilvaSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Daniel Domingues FreitasSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Francisca Bruna Stefany Aires do NascimentoSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Larissa Nara Dantas de AndradeSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Letícia Serpa SampaioSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil.
Thalles Barbosa GrangeiroDepartment of Biology, Science Center, Molecular Genetics Laboratory, Federal University of Ceara, Fortaleza, CE, Brazil.
Hemerson Iury Ferreira MagalhãesSchool of Pharmacy, Federal University of Paraiba, João Pessoa, PB, Brazil.
Bruno Coêlho CavalcantiDepartment of Physiology and Pharmacology, Federal University of Ceara, Fortaleza, CE, Brazil.
Manoel Odorico de MoraesDepartment of Physiology and Pharmacology, Federal University of Ceara, Fortaleza, CE, Brazil.
Hélio Vitoriano Nobre JúniorSchool of Pharmacy, Laboratory of Bioprospection and Experiments in Yeast (LABEL), Federal University of Ceara, Fortaleza, CE, Brazil label_ufc@yahoo.com.br.
Universidade Federal do Ceará · BRUniversidade Federal da Paraíba · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of fungal infections and, in particular, the incidence of fungal antibiotic resistance, which is associated with biofilm formation, have significantly increased, contributing to morbidity and mortality. Thus, new therapeutic strategies need to be developed. In this context, natural products have emerged as a major source of possible antifungal agents. Berberine is a protoberberine-type isoquinoline alkaloid isolated from the roots, rhizomes, and stem bark of natural herbs, such as Berberis aquifolium, Berberis vulgaris, Berberis aristata, and Hydrastis canadensis, and of Phellodendron amurense Berberine has been proven to have broad antibacterial and antifungal activity. In the present study, the potential antifungal effect of berberine against fluconazole-resistant Candida and Cryptococcus neoformans strains, as well as against the biofilm form of Candida spp., was assessed. The antifungal effect of berberine was determined by a broth microdilution method (the M27-A3 method of the Clinical and Laboratory Standards Institute) and flow cytometry techniques, in which the probable mechanism of action of the compound was also assessed. For biofilm assessment, a colorimetric 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used to determine the susceptibility of sessile cells. The isolates used in the study belonged to the Laboratory of Bioprospection and Experiments in Yeast (LABEL) of the Federal University of Ceará. After 24 and 72 h, fluconazole-resistant Candida and Cryptococcus neoformans strains showed berberine MICs equal to 8 μg/ml and 16 μg/ml, respectively. Cytometric analysis showed that treatment with berberine caused alterations to the integrity of the plasma and mitochondrial membranes and DNA damage, which led to cell death, probably by apoptosis. Assessment of biofilm-forming isolates after treatment showed statistically significant reductions in biofilm cell activity (P < 0.001).

Indexed as

AnimalsAntifungal AgentsBerberineBiofilmsCandidaCandidiasisCell LineCell ProliferationCryptococcosisCryptococcus neoformansDNA, FungalDrug Resistance, FungalFluconazoleHumansL CellsMiceAntifungal AgentsBerberineDNA, FungalFluconazole

Identifiers

PMID27021328
PMCPMC4879420
OpenAlexW2315324126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.